Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography

Anadolu Kardiyoloji Dergisi

Volumn 15, Issue 2, 2015, Pages 137-142

  Baktır, Ahmet Oğuz ^a   Şarlı, Bahadır ^a   Emre Altekin, R ^b   Karaman, Ahmet ^a   Arınç, Hüseyin ^a   Sağlam, Hayrettin ^a   Doğan, Yasemin ^a   Erden, Abdulsamet ^a   Karaman, Hatice ^a  

^a KAYSERI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Speckle tracking echocardiography; Subclinical myocardial dysfunction

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC STRAIN; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART STRESS; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; MYOCARDIAL STRAIN; NONALCOHOLIC FATTY LIVER; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTOLIC STRAIN; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; INTERVENTRICULAR SEPTUM DIASTOLIC THICKNESS DIAMETER; ISOVOLUMIC CONTRACTION TIME; ISOVOLUMIC RELAXATION TIME; LEFT ATRIAL VOLUME INDEX; LEFT VENTRICULAR DIASTOLIC DIAMETER; LEFT VENTRICULAR SYSTOLIC DIAMETER; COMPLICATION; ECHOGRAPHY; PROCEDURES;

ADULT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84979092787     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5212     Document Type: Article

References (29)

1. Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology 2007; 46: 1091-100.
2. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-73.
3. Alper AT, Hasdemir H, Şahin S, Ontürk E, Akyol A, Nurkalem Z, et al. The relationship between nonalcoholic fatty liver disease an d the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars 2008; 36: 376-81.
4. Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40: 949-55.
5. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomi-crometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2006; 47: 789-93.
6. Sert A, Aypar E, Pirgon O, Yılmaz H, Odabaş D, Tolu I. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol 2013; 112: 436-43.
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 1440-63.
8. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84.
9. Altekin RE, Yanıkoğlu A, Baktır AO, Karakaş MS, Özel D, Çilli A, et al. Assessment of subclinical left ventricular dysfunction in obstructive sleep apnea patients with speckle tracking echocardiography. Int J Cardiovasc Imaging 2012; 28: 1917-30.
10. Matthews DR, Hosker J P, Rudenski AS, Naylor BA, Treacher D F, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
11. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008; 134: 1369-75.
12. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009; 106: 15430-5.
13. Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J Hepatol 2010; 53: 1146-7.
14. Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000; 24: 28-32.
15. Brindley DN, Kok B P, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2010; 298: 897-908.
16. Mellor KM, Ritchie RH, Delbridge LM. Reactive oxygen species and insülin resistant cardiomyopathy. Clin Exp Pharmacol Physiol 2010; 37: 222-8.
17. McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med 2006; 144: 517-24.
18. Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: 282-90.
19. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-23.
20. Marra F. Nuclear factor-kappaB inhibition and non-alcoholic ste-atohepatitis: inflammation as a target for therapy. Gut 2008; 57: 570-2.
21. Videla LA, Tapia G, Rodrigo R, Pettinelli P, Haim D, Santibañez C, et al. Liver NF-kappaB and AP-1 DNA binding in obese patients. Obesity (Silver Spring) 2009; 17: 973-9.
22. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008; 47: 51-8.
23. Edvardsen T, Helle-Valle T, Smiseth OA. Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echo-cardiography. Prog Cardiovasc Dis 2006; 49: 207-14.
24. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15.
25. Fotbolcu H, Yakar T, Duman D, Karaahmet T, Tigen K, Çevik C, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010; 17: 457-63.
26. Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, Magkos F, et al. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr 2013; 162: 1160-8.
27. Støylen A, Slørdahl S, Skjelvan GK, Heimdal A, Skjaerpe T. Strain rate imaging in normal and reduced diastolic function: comparison with pulsed Doppler tissue imaging of the mitral annulus. J Am Soc Echocardiogr 2001; 14: 264-74.
28. Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35: 389-95.
29. Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol 2013; 58: 757-62.